You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Pegylated liposomal irinotecan in combination for untreated metastatic pancreatic cancer (terminated appraisal)

  • Technology appraisal
  • Reference number: TA1052
  • Published:  02 April 2025
  • Guidance
  • Tools and resources
  • History

28399-Irinotecan-Oxaliplatin-5-Fluorouracil-Leucovorin-for-Pancreatic-Cancer-V1.0-MAY2024-NON-CONF-.pdf (nihr.ac.uk)

This page was last updated: 11 July 2024

Back to top